Labcorp Holdings (LTS:0JSY) NonCurrent Deferred Liabilities: $456 Mil (As of Mar. 2026)


LTS:0JSY Labcorp Holdings Inc LTS:0JSY
81 GF Score
Price $285.29
GF Value $269.55
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Labcorp Holdings NonCurrent Deferred Liabilities?

Labcorp Holdings LTS:0JSY 81 NonCurrent Deferred Liabilities is $456 Mil as of Mar. 2026. GuruFocus rates LTS:0JSY with a GF Score™ of 81/100 and a GF Value™ of $269.55 (Fairly Valued). The stock has 6 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Labcorp Holdings's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $456 Mil.

Labcorp Holdings NonCurrent Deferred Liabilities Related Terms

Labcorp Holdings NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings NonCurrent Deferred Liabilities Chart

Labcorp Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 867.30 640.30 525.30 515.60 605.00

Labcorp Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 388.00 354.50 441.50 605.00 456.40
LTS:0JSY
81GF Score
Labcorp Holdings Inc LTS:0JSY
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $456 Mil mean?
Labcorp Holdings (LTS:0JSY) has a NonCurrent Deferred Liabilities of $456 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Labcorp Holdings and its competitors.
Is Labcorp Holdings' NonCurrent Deferred Liabilities too high?
Labcorp Holdings' current NonCurrent Deferred Liabilities is $456 Mil. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' NonCurrent Deferred Liabilities compare to DGX and GH?
Labcorp Holdings' NonCurrent Deferred Liabilities of $456 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Diagnostics & Research company?
A good NonCurrent Deferred Liabilities depends on the Medical Diagnostics & Research industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current NonCurrent Deferred Liabilities is $456 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $269.55, compared to a current price of $285.29 — trading 5.8% above its estimated fair value. The current NonCurrent Deferred Liabilities is $456 Mil. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current NonCurrent Deferred Liabilities is $456 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of $285.29 is trading 5.8% above its estimated GF Value™ of $269.55. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LTS:0JSY:

  • NonCurrent Deferred Liabilities: $456 Mil
  • GF Value™: $269.55 vs. price of $285.29 (5.8% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labcorp Holdings Business Description

Other Exchanges LH:USAN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score

Get the complete analysis for LTS:0JSY

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$285.29
Price
$269.55
GF Value